Results 61 to 70 of about 1,181 (123)
Intravitreal ranibizumab or conbercept for retinal arterial macroaneurysm: a case series
Background There is no consensus for the standard treatment of retinal arterial macroaneurysm (RAM). Intravitreal anti-vascular endothelium growth factor (anti-VEGF) is an alternative treatment option for RAM. The purpose of this study is to describe the
Zhongjing Lin +4 more
doaj +1 more source
Peipei Wu,1 Panpan Zhang,1 Jing Xu,1 Wenhui Ma,1 Longfei Li,2 Haifeng Xu1 1Department of Uveitis, Eye Institute of Shandong First Medical University, Qingdao Eye Hospital of Shandong First Medical University, Qingdao, People’s Republic of China; 2College
Wu P, Zhang P, Xu J, Ma W, Li L, Xu H
doaj
Profile of conbercept in the treatment of neovascular age-related macular degeneration
Xinmin Lu,1 Xiaodong Sun1–31Department of Ophthalmology, Shanghai First People’s Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, People’s Republic of China; 2Eye Research Institute of Shanghai Jiao Tong University,
Lu XM, Sun XD
doaj
Introduction. To compare the effect and safety of intravitreal conbercept (IVC), intravitreal ranibizumab (IVR), or intravitreal triamcinolone acetonide (IVTA) injection on 23-gauge (23-G) pars plana vitrectomy (PPV) for proliferative diabetic ...
Jinglin Cui +8 more
doaj +1 more source
Luping Wang,1 Canwei Zhang,2 Rui Hua3 1Department of Ophthalmology, University of Bonn, Bonn, Germany; 2Department of Ophthalmology, Weifang Eye Hospital, Weifang, People’s Republic of China; 3Department of Ophthalmology, First Hospital of China ...
Wang LP, Zhang CW, Hua R
doaj
Yuting Peng, Xiongze Zhang, Miaoling Li, Bing Liu, Lan Mi, Chengguo Zuo, Feng Wen State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, China Introduction: To evaluate the functional and morphological ...
Peng Y +6 more
doaj
Two-year outcomes of intravitreal conbercept therapy for polypoidal choroidal vasculopathy
Background This study aims to evaluate the two-year outcomes of polypoidal choroidal vasculopathy (PCV) treated with conbercept and to investigate the predictive response factors.
Yang Liu +4 more
doaj +1 more source
Chen Sun,1,* Shuyue Zhang,1,* Nan Xu,1,* Kun Liu,2 Fang Wei,2 Xiaoqian Zhang,1 Jigang Zhang,1 Shen Gao,3 Yuan Yu,4 Xueying Ding1 1Clinical Research Center, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai,
Sun C +9 more
doaj
Intravitreal conbercept combined with panretinal photocoagulation improves efficacy and reduces inflammatory factors in diabetic macular edema: a retrospective study. [PDF]
Qin Y, Li N, Zhu Y.
europepmc +1 more source

